Cargando…
Effect of esketamine on postoperative depressive symptoms in patients undergoing thoracoscopic lung cancer surgery: A randomized controlled trial
BACKGROUND: Depressive symptoms are common among patients with lung cancer. We aimed to assess the effects of esketamine on postoperative depressive symptoms after thoracoscopic lung cancer surgery. METHODS: In this randomized, double-blind, placebo-controlled trial, 156 patients undergoing thoracos...
Autores principales: | Gan, Shu-lin, Long, Yu-qin, Wang, Qin-yun, Feng, Chang-dong, Lai, Chen-xu, Liu, Chun-tong, Ding, Yun-ying, Liu, Hong, Peng, Ke, Ji, Fu-hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050377/ https://www.ncbi.nlm.nih.gov/pubmed/37009103 http://dx.doi.org/10.3389/fpsyt.2023.1128406 |
Ejemplares similares
-
Case report: Intranasal esketamine for severe major depressive disorder with psychotic features
por: Carter, Maximilian, et al.
Publicado: (2022) -
Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review
por: Sapkota, Alisha, et al.
Publicado: (2021) -
Intranasal esketamine as therapeutic option: a case report of an adolescent with treatment resistant depression
por: Skala, Katrin, et al.
Publicado: (2023) -
Effect of postoperative application of esketamine on postoperative depression and postoperative analgesia in patients undergoing pancreatoduodenectomy: a randomized controlled trial protocol
por: Yu, Kaili, et al.
Publicado: (2023) -
Case report: Effectiveness of brexpiprazole and esketamine/ketamine combination: A novel therapeutic strategy in five cases of treatment-resistant depression
por: Chan, Lai Fong, et al.
Publicado: (2022)